2024-09-30 - Analysis Report
## Intuitive Surgical Inc (ISRG) Stock Analysis: 

**Company Overview:** Intuitive Surgical Inc. is a leading medical device company that designs, manufactures, and sells minimally invasive surgical systems.

**Performance Analysis:**

1. **Performance vs S&P 500:** 
   - ISRG's cumulative return (348.42%) significantly outperforms the S&P 500 (VOO) cumulative return (133.28%).
   - The difference in returns is currently 215.14%, ranking at the 74.46% percentile of historical performance relative to the S&P 500. 

2. **Recent Price Action:**
   - Closing Price: $482.12
   - 5-day Moving Average: $485.26 
   - 20-day Moving Average: $485.14
   - 60-day Moving Average: $466.60
   - ISRG is trading slightly below its 5-day and 20-day moving averages, indicating potential short-term consolidation.

3. **Technical Indicators:**
   - RSI: 52.72 -  The stock is currently in the neutral zone, indicating neither overbought nor oversold conditions.
   - PPO: -0.32 - The negative value indicates a slight bearish momentum, suggesting potential for short-term downward price movement.
   - Delta_Previous_Relative_Divergence: -3.46  - The negative value indicates a short-term downward trend in relative divergence, which means ISRG is underperforming the market.
   - Expected Return: 14.96% - This is the maximum 5-year projected return based on current investment amount.

4. **Recent Earnings and Outlook:**

   | Date       | EPS     | Revenue   |
   |------------|---------|-----------|
   | 2024-07-19 | 1.48    | $2.01 B    |
   | 2024-04-19 | 1.54    | $1.89 B    |
   | 2023-10-20 | 1.18    | $1.74 B    |
   | 2023-07-24 | 1.20    | $1.76 B    |
   | 2024-07-19 | 1.20    | $1.76 B    |

   - The most recent earnings report (2024-07-19) shows an EPS of 1.48, which surpassed analyst expectations of 1.20. 
   - Revenue also exceeded estimates, reaching $2.01 billion. 
   - Strong earnings growth and exceeding expectations highlight the company's strong performance and potential for future growth.

5. **News & Recent Issues:**

   - **Recent Market Outlook:** 
      - FINBOLD reported ISRG stock to be a "buy" with a price target of $525. 
      - Analyst sentiment remains positive with several firms citing ISRG's strong market position and growth potential.
   - **Performance Highlights:** 
      - ISRG has consistently surpassed earnings expectations, demonstrating strong demand for its products and services.
      - The company continues to expand its product portfolio and explore new markets. 

**Overall Analysis:**

ISRG has consistently outperformed the broader market, driven by strong earnings performance and a dominant position in the minimally invasive surgery market. While short-term technical indicators suggest some potential downward pressure, the long-term growth potential remains strong, supported by increasing adoption of robotic surgery and a robust product pipeline. The company's continued focus on innovation and market expansion creates opportunities for sustained growth and shareholder value.

**Disclaimer:** This analysis is for informational purposes only and should not be considered as financial advice. It is important to consult with a qualified financial professional before making any investment decisions.
